RopesTalk

On this episode of Ropes & Gray’s Antitrust Insights podcast series, strategic transactions partner Hannah England is joined by antitrust partners Jackie Grise and Zak Goodwin to discuss the practical implications of the new Hart–Scott–Rodino (“HSR”) Act rules, which go into effect on February 10, 2025, and the challenges faced by pharmaceutical clients and the strategic adjustments required for compliance. Tune in to understand how these changes will affect acquisitions, licensing and collaboration transactions and other strategic transactions, as well as the overall regulatory landscape. 

Welcome to the R&G Dugout, a new Ropes & Gray podcast series that delves into the dynamic world of sports investing, with a particular focus on the evolving ecosystem of media, entertainment, and private capital ventures. On this inaugural episode, Ropes & Gray partners Amanda Persaud, Patrick Dorime, and Erica Han discuss the transformative changes occurring in the sports industry, from the recent updates in ownership rules in professional leagues to the burgeoning interest in college athletics and private capital investments. This episode provides a foundational background in the sports investment landscape, addressing key questions about structuring investments, navigating regulatory complexities, and leveraging cross-disciplinary legal experience. Tune in to learn how Ropes & Gray and industry insiders are shaping the future of sports transactions. 

Danny Mayhew, Global Head of Organisational Justice at Sanofi, brings a wealth of experience from law enforcement to corporate compliance. He discusses the crucial role of empathy in investigations and how fostering organizational justice can enhance workplace fairness. The conversation delves into leveraging AI and machine learning for predictive compliance, promoting transparency through data insights, and the establishment of an internal ombuds office for conflict resolution. Danny emphasizes the need for a supportive culture and proactive measures to prevent misconduct.

On this episode of Ropes & Gray’s podcast series A Word for Our Sponsors, Deb Lussier, partner and co-leader of the sponsor solutions practice, and Marc Migliazzo, counsel in the sponsor solutions practice, are joined by Darren O’Brien and Chirag Shah, managing directors on the secondary advisory team for Campbell Lutyens. Together, they examine the results of a “North America Private Equity GP-Led Secondary Perceptions” survey they jointly conducted this year, and explore the booming GP-led secondaries market, discussing key trends, the importance of LP-GP alignment, and the strategic use of continuation funds. Tune in to gain valuable insights on how these transactions are shaping the future of private equity. 

Join us for the final episode of our Health Care Transaction Laws Unwrapped podcast series, where Ropes & Gray antitrust partner Jane Willis and counsel David Young explore the intersection of health care transaction laws and antitrust enforcement. They discuss major trends influencing health care transactions, the impact of political changes on antitrust enforcement, and specific issues such as community hospital acquisitions, system-to-system mergers, and private equity investments in health care. The episode provides insights into how these factors shape the regulatory landscape and what health care providers and investors can expect moving forward.

On this episode of Ropes & Gray’s podcast series Non-binding Guidance, health care partner David Peloquin and life sciences regulatory and compliance counsel Sarah Blankstein discuss the FDA's recent draft guidance on diversity action plans (DAPs) aimed at improving the enrollment of underrepresented populations in clinical studies. They examine the implications and challenges sponsors may face in setting and meeting enrollment goals, as well as the potential impact of the recent presidential election on the final guidance. They also address key open questions related to the draft guidance. 

On this episode of Ropes & Gray’s podcast series Controlling Opinions, Josh Oyster, a partner in the life sciences regulatory and compliance practice group, is joined by colleagues Andrew O’Connor, a litigation and enforcement partner, and Beth Weinman, life sciences regulatory and compliance counsel. Together, they delve into the complexities of DEA diversion investigations and how health care entities can prepare for these challenging situations. They discuss the risks involved, the various players in these investigations, and the enforcement consequences that can result. They also provide practical advice on navigating DEA audits and share insights from recent enforcement matters. 

Katie Daniels, the Managing Director and Head of Compliance at CPP Investments, shares her innovative journey using behavioral science to tackle compliance challenges. She emphasizes the human factor in compliance and how authenticity and vulnerability can strengthen trust. Listeners can learn about impactful compliance interventions, the importance of organizational culture, and the need for open communication. Plus, Katie reveals her love for live music and theater, adding a creative twist to compliance discussions!

On this episode of Women @ RopesTalk hosted by health care and data partner Christine Moundas, litigation & enforcement partner Sarah Walters is joined by Veronica Lei, the associate vice president and assistant general counsel for Eli Lilly's Diabetes Alliance. Veronica shares her diverse career journey from being a federal prosecutor to her current role at Eli Lilly, discussing her experiences in litigation, internal investigations and business counseling. She also reflects on the importance of balancing professional and personal life and offers valuable advice for aspiring legal professionals.

On this episode of Ropes & Gray’s Health Care Transaction Laws Unwrapped podcast series, health care attorneys Christina Bergeron and Natalie LaRue discuss recent developments in state health care transaction laws and their impacts on private equity investments in health care. With an increase in transaction laws specifically targeting private equity, including passed legislation in Indiana and bills that were considered in California, Massachusetts, Connecticut and Minnesota, they discuss the effects these laws have on the dealmaking landscape and key takeaways for these investors.